Potent Antiplatelet Therapy May Reduce Death from Sepsis in Patients on Chronic Dialysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Potent Antiplatelet Therapy May Reduce Death from Sepsis in Patients on Chronic Dialysis

Published:2022-01 Issue: Volume:162 Page:209-211
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Jain Nishank^ORCID,Phadnis Milind A.^ORCID,Martin Bradley C.,Mehta Jawahar L.^ORCID

Funder

American Society of Nephrology

National Center for Advancing Translational Sciences

Translational Research Institute, University of Arkansas for Medical Sciences

National Institutes of Health

American Heart Association

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference5 articles.

1. 2020 USRDS annual data report: Epidemiology of kidney disease in the United States,2020

2. Comparative Effectiveness and Safety of Oral P2Y12 Inhibitors in Patients on Chronic Dialysis;Jain;Kidney Int Rep,2021

3. Effect of P2Y12 inhibitors on inflammation and immunity;Thomas;Thromb Haemost,2015

4. Role of platelets in chronic kidney disease;Jain;J Am Soc Nephrol,2021

5. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population;Sarnak;Kidney Int,2000

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platelets, inflammation, and purinergic receptors in chronic kidney disease;Kidney International;2024-09

2. Updates on New Therapies for Patients with CKD;Kidney International Reports;2024-01

3. Ticagrelor inhibits platelet aggregation and reduces inflammatory burden more than clopidogrel in patients with stages 4 or 5 chronic kidney disease;Vascular Pharmacology;2023-02

4. Platelet-Dependent Inflammatory Dysregulation in Patients with Stages 4 or 5 Chronic Kidney Disease: A Mechanistic Clinical Study;Kidney360;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3